Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03934411Not ApplicableCompleted

Effect of Increased Pain Tolerance on Exercise Performance

Role: collaborator

NCT00262587Phase 4Completed

Elite Sport and Development of Asthma

Role: collaborator

NCT00832663Not ApplicableCompleted

Influence of Non-steroidal Anti-inflammatory Drugs (NSAID) on Muscle Regeneration

Role: collaborator

NCT00207038Completed

Airway Inflammation in Swimmers

Role: collaborator

All 4 trials loaded